LYCOS RETRIEVER 
Depression: Studies
built 641 days ago
Depression and diabetes are two of the most commonly treated health problems treated in primary care settings. Previous studies have drawn a link between diabetes and depression, and between the combination of the two an increased risk of premature death. This is the first known study to examine the relationship between diabetes and mortality in a depression intervention trial.
Source:
Because depression runs in families, and has a strong genetic component, compelling evidence suggests that depression is a biologic phenomenon. Data from family, twin, adoption, and genetic studies have confirmed this. Studies have found that first-degree relatives of patients with depression are two to six times more likely to develop the problem than individuals without a family history.
Source:
A number of large-scale studies indicate that depression rates have increased worldwide over the past several decades. Furthermore, younger generations are experiencing depression at an earlier age than did previous generations. Social scientists have proposed many explanations, including changes in family structure, urbanization, and reduced cultural and religious influences.
Source:
Chronic depression is a frequent companion to anxiety disorders. In one study, up to 96% of patients with depressive disorders experienced concurrent anxiety. More than two-thirds of people with obsessive-compulsive disorder, a common anxiety disorder... suffer from depression.
Source:
ADHD costs USA more than drug abuse and depression - "ADHD (Attention deficit hyperactivity disorder) is much more common in the USA than most people realise – ADHD costs sufferers approximately $77 billion every year. This is more than the total costs of drug abuse and depression, according to a new study carried out at Harvard University, USA.," by Medical News Today
Source:
COSTA MESA, Calif., Oct. 25 /PRNewswire-FirstCall/ -- CNS Response, Inc. CNSO announced today that it has conducted a quality assurance analysis of its current multi-center trial of rEEGSM -guided pharmacotherapy for individuals with treatment-resistant depression. Based on the evaluation, CNS Response is amending the design of the study in order to address issues related to functionality and operability.
Source:
MORE ABOUT
Studies